According to the pharmaceutical industry association, Farmaindustria, 40% of orphan drugs approved i...
Read moreThe National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s Zej...
Read moreThe Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...
Read moreThe Italian Medicines Agency (AIFA) has announced that Roche’s Evyrsdi (risdiplam) is reimbursed w...
Read moreThe news comes after the health service negotiated a “significant confidential discount” to the ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWhen making a decision about the approval of a new product NICE (National Institute for Health and C...
Read moreInnovative therapies for rare diseases may only be available in a select number of countries in Euro...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreNHS England, the UK’s publicly funded healthcare system, will be introducing a £340m fund dedicat...
Read more